Ocular Imaging With Spectral Domain Optical Coherence Tomography

Yonsei University

Status: Unknown

Conditions: Myopia; Healthy; Hypermetropia

Treatments: Device: Spectral domain-OCT (Cirrus™ HD-OCT, Carl Zeiss Meditec AG)

Study type: Interventional

Funder types: Other

Identifiers

NCT00926549

3-2008-0048

Details and patient eligibility

About

The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with various ocular diseases.

Full description

Assessment of macular thickness is important for the treatment and follow-up of a variety of ocular diseases. The introduction of optical coherence tomography (OCT) has enabled clinicians to reliably detect small changes in macular thickness and to quantitatively evaluate the efficacy of different therapeutic modalities. In this study using the spectral domain-OCT, we examined the variations of macular retinal thickness and macular volume in normal eyes and in eyes with various ocular diseases.

Enrollment: 300 estimated patients

Sex: All

Ages: 16 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• normal eyes
• myopic eyes
• hypermetropic eyes

Exclusion criteria

• systemic illness
• cataract
• previous ocular trauma or surgery(other than cataract surgery or refractive surgeries)

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

300 participants in 1 patient group

spectral domain-OCT

Experimental group

Description:

Spectral domain-OCT scanning performed.

Treatment:

Device: Spectral domain-OCT (Cirrus™ HD-OCT, Carl Zeiss Meditec AG)